Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its AllplexTM SARS-CoV-2/FluA/FluB/RSV Assay
Real-time test differentiates influenza A & B, RSV and COVID-19
SEOUL, South Korea–(BUSINESS WIRE)–Seegene Inc. (KQ096530), a biotechnology company specializing in molecular diagnostics, has submitted its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay …